Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$572M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$495M |
| 3 |
iShares MBS ETF
MBB
|
+$405M |
| 4 |
Procter & Gamble
PG
|
+$365M |
| 5 |
Microsoft
MSFT
|
+$327M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$605M |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$544M |
| 3 |
Sempra
SRE
|
+$474M |
| 4 |
CELG
Celgene Corp
CELG
|
+$411M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$380M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.85% |
| 2 | Healthcare | 5.77% |
| 3 | Financials | 5.26% |
| 4 | Consumer Discretionary | 4.71% |
| 5 | Communication Services | 4.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4551
Daily Journal
DJCO
$805M
| $335K | ﹤0.01% |
1,155
+575
| +99% | +$161K |
|
|
GRA
4552
CALL
DELISTED
W.R. Grace & Co.
GRA
| $335K | ﹤0.01% |
4,800
+800
| +20% | +$53.7K |
|
4553
Timberland Bancorp
TSBK
$348M
| $334K | ﹤0.01% |
11,235
+3,599
| +47% | +$101K |
|
|
SPWR
4554
PUT
DELISTED
SunPower Corporation Common Stock
SPWR
| $333K | ﹤0.01% |
65,356
-7,635
| -10% | -$42.4K |
|
|
RUBY
4555
DELISTED
Rubius Therapeutics, Inc
RUBY
| $333K | ﹤0.01% |
35,000
+13,965
| +66% | +$135K |
|
|
PCSB
4556
DELISTED
PCSB Financial Corporation
PCSB
| $332K | ﹤0.01% |
16,407
+8,226
| +101% | +$166K |
|
|
HDV
4557
iShares Core High Dividend ETF
HDV
$14.8B
| $331K | ﹤0.01% |
16,875
-76,880
| -82% | -$1.47M |
|
4558
CALL
Quanta Services
PWR
$106B
| $330K | ﹤0.01% |
8,100
-92,000
| -92% | -$3.75M |
|
|
WCG
4559
CALL
DELISTED
Wellcare Health Plans, Inc.
WCG
| $330K | ﹤0.01% |
1,000
-4,900
| -83% | -$1.47M |
|
4560
iShares Latin America 40 ETF
ILF
$3.82B
| $329K | ﹤0.01% |
9,678
-31,749
| -77% | -$1.04M |
|
|
PFNX
4561
DELISTED
Pfenex Inc.
PFNX
| $329K | ﹤0.01% |
30,020
+14,807
| +97% | +$147K |
|
4562
PUT
Cameco
CCJ
$41.1B
| $328K | ﹤0.01% |
36,900
+22,600
| +158% | +$209K |
|
4563
Primis Financial Corp
FRST
$410M
| $328K | ﹤0.01% |
20,084
+9,995
| +99% | +$158K |
|
|
MTOR
4564
CALL
DELISTED
MERITOR, Inc.
MTOR
| $327K | ﹤0.01% |
12,500
+11,800
| +1,686% | +$266K |
|
4565
Spok Holdings
SPOK
$232M
| $326K | ﹤0.01% |
26,682
+8,821
| +49% | +$104K |
|
4566
CALL
Franklin Resources
BEN
$18.2B
| $325K | ﹤0.01% |
12,500
-26,900
| -68% | -$731K |
|
4567
Grand Canyon Education
LOPE
$3.91B
| $325K | ﹤0.01% |
3,398
-27,558
| -89% | -$2.54M |
|
4568
NWPX Infrastructure Inc
NWPX
$1.25B
| $325K | ﹤0.01% |
9,759
+4,889
| +100% | +$154K |
|
|
RDUS
4569
CALL
DELISTED
Radius Recycling
RDUS
| $325K | ﹤0.01% |
15,000
+14,200
| +1,775% | +$302K |
|
4570
CRISPR Therapeutics
CRSP
$5.18B
| $324K | ﹤0.01% |
5,309
-8,568
| -62% | -$468K |
|
|
TBIO
4571
DELISTED
Translate Bio, Inc. Common Stock
TBIO
| $324K | ﹤0.01% |
39,829
+21,316
| +115% | +$197K |
|
4572
CALL
Dover
DOV
$28.2B
| $323K | ﹤0.01% |
2,800
-2,500
| -47% | -$268K |
|
4573
CALL
Macerich
MAC
$7.26B
| $323K | ﹤0.01% |
12,000
-30,000
| -71% | -$824K |
|
4574
PUT
Direxion Daily S&P 500 Bear 3x ETF
SPXS
$307M
| $323K | ﹤0.01% |
244
+36
| +17% | +$55.5K |
|
4575
CALL
Winnebago Industries
WGO
$901M
| $323K | ﹤0.01% |
6,100
-2,900
| -32% | -$136K |
|
Similar funds
Barclays's Q4 2019 Portfolio in Review
As of Q4 2019, Barclays held 7,254 positions worth $180B, up 13% from $160B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Barclays deployed $6.1B of net new capital in Q4 2019, opening 260 new positions and adding to 3,541 existing holdings. Its largest new stake was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
By sector, the portfolio is most concentrated in Technology at 8.9% of assets, up from 7.7% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Invesco QQQ Trust, an estimated $605M trimmed.
- Barclays's largest Q4 2019 buy was Pacer iPath Gold ETNs: 1,000,000 shares worth $25.3M.
- Barclays added most to Apple in Q4 2019, an estimated $572M increase.
- Barclays's biggest Q4 2019 reduction was Invesco QQQ Trust, cutting an estimated $605M.
- Barclays fully exited Celgene Corp in Q4 2019, selling an estimated $411M.
- Barclays's ten largest holdings make up 26% of its $180B portfolio in Q4 2019.
- Barclays opened 260 new positions and closed 700 in Q4 2019.
- Barclays's portfolio value rose 13% quarter-over-quarter to $180B.
Based on Barclays's 13F filing for Q4 2019, filed 10 Feb 2020.